Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography ( <sup>68</sup> Ga PSMA PET/CT) outperforms CT and bone scintigraphy in terms of diagnostic accuracy for the primary staging of prostate cancer and has become widely used. The gene discussed is FOLH1; the disease is prostate cancer.